Disease relapse and infectious complications as the main cause of stem cell transplant failure
Journal Title: Postępy Nauk Medycznych - Year 2013, Vol 26, Issue 9
Abstract
Introduction. Hematopoietic stem cell transplantation (HSCT) is an important therapeutic method in hematology, oncology and immunology.Aim. The general overview of the results of HSCT in Bydgoszcz Transplant Center with respect to donor type.Material and methods. Between 2003 to June 2013, a total number of 241 of hematopoietic stem cell transplantations were performed in Department of Pediatric Hematology and Oncology, Collegium Medicum, Bydgoszcz, including 130 allogeneic (51 family and 60 unrelated donors) and 111 autologous HSCT. In 20 patients, more than 1 transplantation was performed.Results. A total of 143/221 (64.7%) patients were alive at the end of the follow-up. Among auto-HSCT patients 29/102 (28.5%) has died due to disease relapse/progression (n = 25, i.e. 24.6%) or transplant-related complications (n = 4, i.e. 3.9%). TRM included transplant toxicity (n = 3) or infections (n = 1). Among allo-HSCT patients 49/119 (41.2%) has died due to disease relapse/progression (n = 19, i.e. 15.8%) or transplant-related complications (n = 30, i.e. 25%). TRM included infections (n = 18, i.e. 60%), GVHD (n = 7, i.e. 23.3%) or transplant toxicity (n = 5, i.e. 16.7%). The median follow-up of survivors estimated by Kaplan-Meier method was 5.8 years. Probability of overall survival (pOS) for all patients was 0.61 ± 0.03. pOS after allo-HSCT was 0.56 ± 0.06, and after auto-HSCT was 0.65 ± 0.06. pOS after matched family donor HSCT was 0.66 ± 0.07 and after alternative donor HSCT 0.48 ± 0.07. With respect to unrelated donors, pOS was 0.49 ± 0.09 for 10/10 HLA-matched donors (MUD-HSCT), 0.52 ± 0.11 for 9/10 HLA-matched donors and 0.20 ± 0.18 for 8/10 HLA-matched donors.Conclusion. Disease relapse and infectious complications are the main cause of allogeneic stem cell transplant failure, while disease relapse is the main cause of autologous transplant failure.
Authors and Affiliations
Jan Styczyński, Robert Dębski, Anna Krenska, Krzysztof Czyżewski, Ninela Irga, Magdalena Szalewska, Elżbieta Adamkiewicz-Drożyńska, Marcin Płonowski, Maryna Krawczuk-Rybak, Tomasz Ociepa, Monika Pogorzała, Mariusz Wysocki
Keywords
Related Articles
- EP ID EP54789
- DOI -
- Views 148
- Downloads 0
Treatment of distal radial fractures in elderly patients
Fractures of distal radius make up to 30% of all fractures in patients over 50 years of age. Primary goal of treatment of these fractures is preservation of hand and forearm function. Aggressiveness of treatment regimen...
Endovascular mechanical thrombectomy of primary and recurrent changes in the arteries and bypasses – preliminary own experience
Introduction. Atherosclerosis is the most common disease of lower extremity arteries and a main cause of chronic limb ischemia. Treatment options of advanced peripheral arterial disease include surgical methods (endarter...
Treatment with the thyroid hormone – is it a challenge?
Levothyroxine (L-T4) represents the first-line treatment in patients with primary andcentral hypothyroidism in different periods of life. Although the normal thyroid glandsecretes both thyroxine and triiodothyro nine, cu...
Kardiomiopatia przerostowa u noworodka z rzadkim zespołem genetycznym – trudności diagnostyczne i terapeutyczne
Kardiomiopatia przerostowa charakteryzuje się przerostem mięśnia lewej komory serca, przy braku innej patologii, takiej jak nadciśnienie tętnicze lub wrodzona wada serca. Objawy kliniczne zazwyczaj zależą od wieku dzieck...
Hazards of polypharmacy in neurology
We live and treat our patients in the era of polypharmacy which, recently, has become a common situation rather than an exception. One can imagine intentional polipragmasia, usually with the aim of treatment augmentation...